Cart
sales@molnova.com
MLS-573151
CAS No. 10179-57-4
MLS-573151( —— )
Catalog No. M23224 CAS No. 10179-57-4
MLS-573151 is a selective inhibitor of GTPase Cdc42(EC50 of 2 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 164 | In Stock |
|
| 50MG | 254 | In Stock |
|
| 100MG | 375 | In Stock |
|
| 200MG | 533 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMLS-573151
-
NoteResearch use only, not for human use.
-
Brief DescriptionMLS-573151 is a selective inhibitor of GTPase Cdc42(EC50 of 2 μM).
-
DescriptionMLS-573151 is a selective inhibitor of GTPase Cdc42(EC50 of 2 μM). It is inactive against other GTPases family members, such as Rab2, Rab7, H-Ras, Rac1, Rac 2 and RhoA wild-type. MLS-573151 acts by blocking the binding of GTP to Cdc42.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCdc42
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10179-57-4
-
Formula Weight377.46
-
Molecular FormulaC21H19N3O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1C(N(N=C1C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fan Mao, et al. Transcriptomic Evidence Reveals the Molecular Basis for Functional Differentiation of Hemocytes in a Marine Invertebrate, Crassostrea gigas. Front Immunol. 2020 May 27;11:911.
molnova catalog
related products
-
CDK9-IN-1
CDK9-IN-1 is a potent, selective CDK9 inhibitor with IC50 of 39 nM (CDK9/CycT1), >10-fold selectivity over CDK4 and >100-fold over CDK1/2/3/5/6/7, inhibits HIV-1 replication in cellular assays.
-
DASA-58
DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.
-
HQ461
HQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation, resulting in decreased CDK12 substrate phosphorylation, downregulation of DNA damage response genes, and cell death.
